Clinical Genetics Branch (CGB)
- Alter, Blanche P., M.D., M.P.H.
Study of inherited bone marrow failure syndromes. Using Fanconi's anemia as the prototype for an interdisciplinary approach to elucidate the mechanisms of carcinogenesis in humans.
- Greene, Mark H., M.D.
Familial/hereditary cancers, genetic determinants of outcomes following cancer treatment, as well as intervention studies (cancer screening, surgical risk reduction and chemoprevention) in genetically at-risk populations, genetic modifiers of cancer risk, and leveraging alert clinical observations into novel etiologic insights.
- Kratz, Christian, M.D.
Childhood cancer predisposition syndromes, inherited bone marrow failure syndromes, familial/hereditary cancers, childhood myelodysplastic syndrome and myeloproliferative disorders, as well as developmental disorders that are caused by germline mutations in cancer-related genes.
- Savage, Sharon A., M.D.
Genetic and molecular epidemiology of telomere biology, pediatric cancer etiology, and inherited cancer predisposition syndromes.
- Schiffman, Mark, M.D., M.P.H.
Molecular epidemiology to study the natural history of human papillomavirus infection on the risk of cervical cancer. Applications for cervical cancer prevention.
- Stewart, Douglas, M.D.
Somatic and germline variants increasing tumor risk in neurofibromatosis type 1. Next-generation sequencing of NF1-associated tumors. Characterization and gene identification in novel familial tumor-predisposition syndromes.